Emcure Pharma net profit up 36% at Rs 292 crore

Emcure Pharmaceuticals reported a 23% revenue increase in the first quarter. Ebitda grew 25.8% with improved margins, reflecting productivity gains. Net profit saw a significant 36.2% rise during the period. The company began its five-year plan on a strong footing for FY27. Emcure also completed the acquisition of a minority stake in Gennova Biopharmaceuticals.

Britannia net jumps 14%, sales touch Rs 5,000 crore in Q1

Britannia Industries saw net profit rise fourteen percent in the June quarter. Sales increased eight percent to five thousand crore rupees during the period. Profit growth outpaced revenue growth as the company managed costs. E-commerce and general trade channels saw rapid scaling and robust expansion. The company remains agile to deliver sustainable revenue growth amid…